α- L-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice.
Stilhano RS, Martin PK, de Melo SM, Samoto VY, Peres GB, da Silva Michelacci YM, da Silva FH, Pereira VG, D'Almeida V, da Cruz AT, et al. J Gene Med. 2015 Jan-Feb; 17(1-2):1-13.